GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Gross Profit

Allied Biotech (ROCO:1780) Gross Profit : NT$246.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Allied Biotech Gross Profit?

Allied Biotech's gross profit for the six months ended in Dec. 2023 was NT$117.4 Mil. Allied Biotech's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was NT$246.4 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Allied Biotech's gross profit for the six months ended in Dec. 2023 was NT$117.4 Mil. Allied Biotech's Revenue for the six months ended in Dec. 2023 was NT$341.1 Mil. Therefore, Allied Biotech's Gross Margin % for the quarter that ended in Dec. 2023 was 34.41%.

Allied Biotech had a gross margin of 34.41% for the quarter that ended in Dec. 2023 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Allied Biotech was 42.91%. The lowest was 34.09%. And the median was 37.98%.

Warning Sign:

Allied Biotech Corp gross margin has been in long-term decline. The average rate of decline per year is -3.1%.


Allied Biotech Gross Profit Historical Data

The historical data trend for Allied Biotech's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Biotech Gross Profit Chart

Allied Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 274.38 241.15 258.05 271.05 246.44

Allied Biotech Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.19 125.96 145.08 129.08 117.36

Competitive Comparison of Allied Biotech's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Allied Biotech's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allied Biotech's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Allied Biotech's Gross Profit distribution charts can be found below:

* The bar in red indicates where Allied Biotech's Gross Profit falls into.



Allied Biotech Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Allied Biotech's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=720.431 - 473.992
=246.4

Allied Biotech's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=341.079 - 223.717
=117.4

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$246.4 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Allied Biotech's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=117.4 / 341.079
=34.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Allied Biotech  (ROCO:1780) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Allied Biotech had a gross margin of 34.41% for the quarter that ended in Dec. 2023 => Competition eroding margins


Allied Biotech Gross Profit Related Terms

Thank you for viewing the detailed overview of Allied Biotech's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Biotech (ROCO:1780) Business Description

Traded in Other Exchanges
N/A
Address
No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.

Allied Biotech (ROCO:1780) Headlines

No Headlines